Skip to main content
Top
Published in: Diagnostic Pathology 1/2010

Open Access 01-12-2010 | Short report

Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS)

Authors: Niko Escher, Günther Ernst, Christian Melle, Alexander Berndt, Joachim H Clement, Kerstin Junker, Karlheinz Friedrich, Orlando Guntinas-Lichius, Ferdinand von Eggeling

Published in: Diagnostic Pathology | Issue 1/2010

Login to get access

Abstract

In carcinoma tissues, genetic and metabolic changes not only occur at the tumor cell level, but also in the surrounding stroma. This carcinoma-reactive stromal tissue is heterogeneous and consists e.g. of non-epithelial cells such as fibroblasts or fibrocytes, inflammatory cells and vasculature-related cells, which promote carcinoma growth and progression of carcinomas. Nevertheless, there is just little knowledge about the proteomic changes from normal connective tissue to tumor stroma. In the present study, we acquired and analysed specific protein patterns of small stromal sections surrounding head and neck cell complexes in comparison to normal subepithelial connective tissue. To gain defined stromal areas we used laser-based tissue microdissection. Because these stromal areas are limited in size we established the highly sensitive 'tissue on chip based mass spectrometry' (toc-MS). Therefore, the dissected areas were directly transferred to chromatographic arrays and the proteomic profiles were subsequently analysed with mass spectrometry. At least 100 cells were needed for an adequate spectrum. The locating of differentially expressed proteins enables a precise separation of normal and tumor stroma. The newly described toc-MS technology allows an initial insight into proteomic differences between small numbers of exactly defined cells from normal and tumor stroma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hofmeister V, Schrama D, Becker JC: Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother. 2008, 57: 1-17. 10.1007/s00262-007-0365-5.CrossRefPubMed Hofmeister V, Schrama D, Becker JC: Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother. 2008, 57: 1-17. 10.1007/s00262-007-0365-5.CrossRefPubMed
2.
go back to reference von Eggeling F, Melle C, Ernst G: Microdissecting the proteome. Proteomics. 2007, 7: 2729-2737. 10.1002/pmic.200700079.CrossRefPubMed von Eggeling F, Melle C, Ernst G: Microdissecting the proteome. Proteomics. 2007, 7: 2729-2737. 10.1002/pmic.200700079.CrossRefPubMed
3.
go back to reference Wulfkuhle JD, Liotta LA, Petricoin EF: Proteomic applications for the early detection of cancer. Nature Reviews Cancer. 2003, 3: 267-275. 10.1038/nrc1043.CrossRefPubMed Wulfkuhle JD, Liotta LA, Petricoin EF: Proteomic applications for the early detection of cancer. Nature Reviews Cancer. 2003, 3: 267-275. 10.1038/nrc1043.CrossRefPubMed
4.
go back to reference Kriegova E, Melle C, Kolek V, Hutyrova B, Mrazek F, Bleul A, du Bois RM, von Eggeling F, Petrek M: Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 2006, 173: 1145-1154. 10.1164/rccm.200507-1126OC.CrossRefPubMed Kriegova E, Melle C, Kolek V, Hutyrova B, Mrazek F, Bleul A, du Bois RM, von Eggeling F, Petrek M: Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 2006, 173: 1145-1154. 10.1164/rccm.200507-1126OC.CrossRefPubMed
5.
go back to reference Busch A, Michel S, Hoppe C, Driesch D, Claussen U, von Eggeling F: Proteome Analysis of Maternal Serum Samples for Trisomy 21 Pregnancies Using ProteinChip Arrays and Bioinformatics. J Histochem Cytochem. 2005, 53: 341-343. 10.1369/jhc.4B6377.2005.CrossRefPubMed Busch A, Michel S, Hoppe C, Driesch D, Claussen U, von Eggeling F: Proteome Analysis of Maternal Serum Samples for Trisomy 21 Pregnancies Using ProteinChip Arrays and Bioinformatics. J Histochem Cytochem. 2005, 53: 341-343. 10.1369/jhc.4B6377.2005.CrossRefPubMed
6.
go back to reference Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, Petricoin EF: Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers. 2001, 17: 301-307.PubMedCentralCrossRefPubMed Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, Petricoin EF: Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers. 2001, 17: 301-307.PubMedCentralCrossRefPubMed
7.
go back to reference Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002, 359: 572-577. 10.1016/S0140-6736(02)07746-2.CrossRefPubMed Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002, 359: 572-577. 10.1016/S0140-6736(02)07746-2.CrossRefPubMed
8.
go back to reference Driemel O, Murzik U, Escher N, Melle C, Bleul A, Dahse R: Protein profiling of oral brush biopsies: S100A8 and S100A9 can differentiate between normal, premalignant and tumor cells. Proteomics - Clinical Applications. 2007, 1: 486-493. 10.1002/prca.200600669.CrossRefPubMed Driemel O, Murzik U, Escher N, Melle C, Bleul A, Dahse R: Protein profiling of oral brush biopsies: S100A8 and S100A9 can differentiate between normal, premalignant and tumor cells. Proteomics - Clinical Applications. 2007, 1: 486-493. 10.1002/prca.200600669.CrossRefPubMed
9.
go back to reference Melle C, Ernst G, Escher N, Hartmann D, Schimmel B, Bleul A, Thieme H, Kaufmann R, Felix K, Friess HM, Settmacher U, Hommann M, Richter KK, Daffner W, Täubig H, Manger T, Claussen U, von Eggeling F: Protein Profiling of Microdissected Pancreas Carcinoma and Identification of HSP27 as a Potential Serum Marker. Clin Chem. 2007 Melle C, Ernst G, Escher N, Hartmann D, Schimmel B, Bleul A, Thieme H, Kaufmann R, Felix K, Friess HM, Settmacher U, Hommann M, Richter KK, Daffner W, Täubig H, Manger T, Claussen U, von Eggeling F: Protein Profiling of Microdissected Pancreas Carcinoma and Identification of HSP27 as a Potential Serum Marker. Clin Chem. 2007
10.
go back to reference Barnes L, Eveson JW, Reichart P, Sidransky D: World Health Organization classification of tumours. Pathology & genetics. Head and neck tumours. 2005, International Agency for Research on Cancer (IARC). Lyon, France: IARC Press Barnes L, Eveson JW, Reichart P, Sidransky D: World Health Organization classification of tumours. Pathology & genetics. Head and neck tumours. 2005, International Agency for Research on Cancer (IARC). Lyon, France: IARC Press
11.
go back to reference Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Möller U, Osterloh D, Halbhuber KJ, von Eggeling F: A Technical Triade for Proteomic Identification and Characterization of Cancer Biomarkers. Cancer Res. 2004, 64: 4099-4104. 10.1158/0008-5472.CAN-03-3807.CrossRefPubMed Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Möller U, Osterloh D, Halbhuber KJ, von Eggeling F: A Technical Triade for Proteomic Identification and Characterization of Cancer Biomarkers. Cancer Res. 2004, 64: 4099-4104. 10.1158/0008-5472.CAN-03-3807.CrossRefPubMed
12.
go back to reference Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM: Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiology and Immunology. 2009, 24: 353-360. 10.1111/j.1399-302X.2009.00512.x.CrossRefPubMed Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM: Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiology and Immunology. 2009, 24: 353-360. 10.1111/j.1399-302X.2009.00512.x.CrossRefPubMed
13.
go back to reference Droin N, Hendra JB, Ducoroy P, Solary E: Human defensins as cancer biomarkers and antitumour molecules. Journal of Proteomics. 2009, 72: 918-927. 10.1016/j.jprot.2009.01.002.CrossRefPubMed Droin N, Hendra JB, Ducoroy P, Solary E: Human defensins as cancer biomarkers and antitumour molecules. Journal of Proteomics. 2009, 72: 918-927. 10.1016/j.jprot.2009.01.002.CrossRefPubMed
14.
go back to reference Ramon I, Kleynen P, Body JJ, Karmali R: Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol. 2009 Ramon I, Kleynen P, Body JJ, Karmali R: Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol. 2009
Metadata
Title
Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS)
Authors
Niko Escher
Günther Ernst
Christian Melle
Alexander Berndt
Joachim H Clement
Kerstin Junker
Karlheinz Friedrich
Orlando Guntinas-Lichius
Ferdinand von Eggeling
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2010
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-5-10

Other articles of this Issue 1/2010

Diagnostic Pathology 1/2010 Go to the issue